BCRX
BioCryst Pharmaceuticals Inc
Price:  
10.10 
USD
Volume:  
5,710,096.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Relative Valuation

-158.4%
Upside

As of 2025-06-22, the Relative Valuation of BioCryst Pharmaceuticals Inc (BCRX) is (5.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.10 USD, the upside of BioCryst Pharmaceuticals Inc based on Relative Valuation is -158.4%.

The range of the Relative Valuation is (5.47) - (6.69) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.4x - 26.2x 23.8x
Forward P/E multiples 16.3x - 28.5x 22.4x
Fair Price (5.47) - (6.69) (5.90)
Upside -154.1% - -166.3% -158.4%
10.10 USD
Stock Price
(5.90) USD
Fair Price

BCRX Relative Valuation - Historical P/E Data

Date P/E
2025-06-12 -41.29
2025-06-11 -41.52
2025-06-10 -43.09
2025-06-09 -43.48
2025-06-06 -43.20
2025-06-05 -42.97
2025-06-04 -43.20
2025-06-03 -43.79
2025-06-02 -41.99
2025-05-30 -42.07
2025-05-29 -42.58
2025-05-28 -41.33
2025-05-27 -42.23
2025-05-23 -41.44
2025-05-22 -40.66
2025-05-21 -39.41
2025-05-20 -40.43
2025-05-19 -40.58
2025-05-16 -40.07
2025-05-15 -39.96
2025-05-14 -38.55
2025-05-13 -39.37
2025-05-12 -40.46
2025-05-09 -39.02
2025-05-08 -38.82
2025-05-07 -39.45
2025-05-06 -40.19
2025-05-05 -43.16
2025-05-02 -34.95
2025-05-01 -34.09
2025-04-30 -34.63
2025-04-29 -33.03
2025-04-28 -32.56
2025-04-25 -32.83
2025-04-24 -32.17
2025-04-23 -31.15
2025-04-22 -30.60
2025-04-21 -29.47
2025-04-17 -28.96
2025-04-16 -28.25
2025-04-15 -28.96
2025-04-14 -27.55
2025-04-11 -26.69
2025-04-10 -25.08
2025-04-09 -26.49
2025-04-08 -25.32
2025-04-07 -26.57
2025-04-04 -26.73
2025-04-03 -28.69
2025-04-02 -29.08